Pomalidomide, Dexamethasone, and Filgrastim-sndz in Treating Patients With Relapsed or Refractory Multiple Myeloma

Clinical trial NCT01946152 · TERMINATED

Trial details

NCT number: NCT01946152
Sponsor: M.D. Anderson Cancer Center
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma-Light Chain Only Recurrent Plasma Cell Myeloma Refractory Plasma Cell Myeloma

Start date: 2014-03-05
Primary completion: 2020-03-18
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.